HK1134902A1 - Compounds a-r-x for the manufacture of pharmaceutical preparations - Google Patents

Compounds a-r-x for the manufacture of pharmaceutical preparations

Info

Publication number
HK1134902A1
HK1134902A1 HK09111940.9A HK09111940A HK1134902A1 HK 1134902 A1 HK1134902 A1 HK 1134902A1 HK 09111940 A HK09111940 A HK 09111940A HK 1134902 A1 HK1134902 A1 HK 1134902A1
Authority
HK
Hong Kong
Prior art keywords
compounds
manufacture
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
HK09111940.9A
Other languages
English (en)
Inventor
Dieter Mueller-Enoch
Thomas Haehner
Original Assignee
Dieter Mueller-Enoch
Thomas Haehner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Mueller-Enoch, Thomas Haehner filed Critical Dieter Mueller-Enoch
Publication of HK1134902A1 publication Critical patent/HK1134902A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK09111940.9A 2006-04-28 2009-12-18 Compounds a-r-x for the manufacture of pharmaceutical preparations HK1134902A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006019906A DE102006019906A1 (de) 2006-04-28 2006-04-28 Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
PCT/DE2007/000768 WO2007124734A2 (de) 2006-04-28 2007-04-27 Verbindungen a-r-x zur herstellung von pharmazeutischen zubereitungen

Publications (1)

Publication Number Publication Date
HK1134902A1 true HK1134902A1 (en) 2010-05-20

Family

ID=38462536

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111940.9A HK1134902A1 (en) 2006-04-28 2009-12-18 Compounds a-r-x for the manufacture of pharmaceutical preparations

Country Status (15)

Country Link
US (1) US8153676B2 (ru)
EP (1) EP2023911B1 (ru)
JP (1) JP2009535309A (ru)
KR (1) KR101113436B1 (ru)
CN (1) CN101478960B (ru)
AU (1) AU2007246023B2 (ru)
BR (1) BRPI0710796A2 (ru)
CA (1) CA2650577C (ru)
DE (2) DE102006019906A1 (ru)
HK (1) HK1134902A1 (ru)
IL (1) IL194961A0 (ru)
MX (1) MX2008013829A (ru)
RU (3) RU2446801C2 (ru)
UA (1) UA93709C2 (ru)
WO (1) WO2007124734A2 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007051339A1 (de) 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
DE102010012233A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Imidazole
DE102010012232A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Irnidazole
DE102010012225A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Kosmetikum
DE102010012226A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Pharmazeutisches Kombinationspräparat
DE102010012224A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Pharmazeutisches Präparat
DE102010012234A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Pharmazeutisches Kombinationspräparat
DE102010012223A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Pharmazeutisches Präparat
DE102010012235A1 (de) 2010-03-19 2011-09-22 Acrovis Biostructures Gmbh Imidazole
KR102055395B1 (ko) 2011-06-24 2019-12-12 쥐알아이 바이오,아이엔씨. 염증 질환의 예방 및 치료
DE102011112103A1 (de) 2011-09-02 2013-03-07 Acrovis Biostructures Gmbh Pharmazeutisches Präparat
DE102012018052A1 (de) 2011-09-21 2013-03-21 Acrovis Biostructures Gmbh Pharmazeutisches Kombinationspräparat
WO2013082458A1 (en) 2011-12-02 2013-06-06 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN105541727B (zh) * 2016-01-15 2018-01-30 徐州医学院 一种具放疗增敏功能的脂质分子、其制备方法及其在肿瘤放射治疗药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS591415A (ja) * 1982-06-28 1984-01-06 Mochida Pharmaceut Co Ltd 循環系疾患治療剤
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
US5436269A (en) 1991-11-14 1995-07-25 Sagami Chemical Research Center Method for treating hepatitis
US20020183333A1 (en) * 2000-03-29 2002-12-05 Shah Sudhir V. Compositions and methods for chemotherapy having reduced nephrotoxicity
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation

Also Published As

Publication number Publication date
RU2008146974A (ru) 2010-06-10
KR20090023590A (ko) 2009-03-05
JP2009535309A (ja) 2009-10-01
MX2008013829A (es) 2009-04-03
DE112007001669A5 (de) 2009-04-16
AU2007246023A1 (en) 2007-11-08
KR101113436B1 (ko) 2012-03-16
WO2007124734A3 (de) 2008-02-07
RU2446801C2 (ru) 2012-04-10
CN101478960B (zh) 2012-06-06
BRPI0710796A2 (pt) 2011-08-09
RU2009113390A (ru) 2010-10-20
US8153676B2 (en) 2012-04-10
CA2650577A1 (en) 2007-11-08
DE102006019906A1 (de) 2007-10-31
IL194961A0 (en) 2009-08-03
UA93709C2 (ru) 2011-03-10
WO2007124734A2 (de) 2007-11-08
RU2477275C1 (ru) 2013-03-10
CN101478960A (zh) 2009-07-08
EP2023911B1 (de) 2013-07-03
EP2023911A2 (de) 2009-02-18
AU2007246023B2 (en) 2012-08-16
US20090191262A1 (en) 2009-07-30
CA2650577C (en) 2013-01-15

Similar Documents

Publication Publication Date Title
HK1134902A1 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
ZA200809546B (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0501999D0 (en) Pharmaceutical compounds
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
GB0512643D0 (en) Pharmaceutical compounds
HUP0700756A2 (en) Process for the preparation of pharmaceutical intermediers
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
EP1948199A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS
PL2219611T3 (pl) Farmaceutyczne postacie do uwalniania związków czynnych
GB0501475D0 (en) Pharmaceutical compounds
GB0613520D0 (en) Pharmaceutical compounds
GB0608397D0 (en) Pharmaceutical compounds
GB0608172D0 (en) Pharmaceutical compounds
GB0608179D0 (en) Pharmaceutical compounds
GB0615293D0 (en) Pharmaceutical compounds
GB0614456D0 (en) Pharmaceutical compounds
GB0608178D0 (en) Pharmaceutical compounds
GB0615299D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160427